Mortality after atypical femoral fractures: A cohort study

Journal of Bone and Mineral Research

Volumn 31, Issue 3, 2016, Pages 491-497

  Kharazmi, Mohammad ^a   Hallberg, Pär ^a   Schilcher, Jörg ^b   Aspenberg, Per ^b   Michaëlsson, Karl ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

ATYPICAL FRACTURE; BISPHOSPHONATES; FEMORAL FRACTURE; MORTALITY; OSTEOPOROSIS

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; ATYPICAL FEMORAL FRACTURE; BONE RADIOGRAPHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; FEMUR FRACTURE; FEMUR SHAFT FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; CHEMICALLY INDUCED; CONFIDENCE INTERVAL; EPIDEMIOLOGY; KAPLAN MEIER METHOD; SWEDEN;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CONFIDENCE INTERVALS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; SWEDEN;

EID: 84954158022     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2767     Document Type: Article

References (45)

1. Chrischilles EA, Butler CD, Davis CS, Wallace RB., A model of lifetime osteoporosis impact. Arch Intern Med. 1991; 151 (10): 2026-32.
2. Hernlund E, Svedbom A, Ivergard M, et al., Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013; 8 (1-2): 136.
3. Wysowski DK, Greene P., Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. Bone. 2013; 57 (2): 423-8.
4. Schousboe JT, Ensrud KE., Diagnostic criteria for osteoporosis should not be expanded. Lancet Diabetes Endocrinol. 2015; 3 (4): 236-8.
5. Jarvinen TL, Michaelsson K, Jokihaara J, et al., Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ. 2015; 350: h2088.
6. Shane E, Burr D, Abrahamsen B, et al., Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014; 29 (1): 1-23.
7. Schilcher J, Koeppen V, Aspenberg P, Michaelsson K., Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014; 371 (10): 974-6.
8. Schilcher J, Koeppen V, Aspenberg P, Michaelsson K., Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop. 2015; 86 (1): 100-7.
9. Schilcher J, Michaëlsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364 (18): 1728-37.
10. Schilcher J, Koeppen V, Ranstam J, Skripitz R, Michaelsson K, Aspenberg P., Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone. 2013; 52 (1): 389-92.
11. Schilcher J, Michaelsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364 (18): 1728-37.
12. Shane E, Burr D, Ebeling PR, et al., Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25 (11): 2267-94.
13. Schilcher J, Sandberg O, Isaksson H, Aspenberg P., Histology of 8 atypical femoral fractures: remodeling but no healing. Acta Orthop. 2014; 85 (3): 280-6.
14. Haentjens P, Magaziner J, Colon-Emeric CS, et al., Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010; 152 (6): 380-90.
15. Michaelsson K, Nordstrom P, Nordstrom A, et al., Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins. J Bone Miner Res. 2014; 29 (2): 424-31.
16. Kharazmi M, Hallberg P., Bisphosphonate-associated atypical femoral fractures and one-year mortality. Ups J Med Sci. 2014; 119 (4): 357-8.
17. Mackey DC, Lui LY, Cawthon PM, et al., High-trauma fractures and low bone mineral density in older women and men. JAMA. 2007; 298 (20): 2381-8.
18. Bergstrom MF, Byberg L, Melhus H, Michaelsson K, Gedeborg R., Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev. 2011; 17 (2): 108-13.
19. Schilcher J., High revision rate but good healing capacity of atypical femoral fractures. A comparison with common shaft fractures. Injury. 2015; 46 (12): 2468-73.
20. Schilcher J, Michaelsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364 (18): 1728-37.
21. Quan H, Sundararajan V, Halfon P, et al., Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43 (11): 1130-9.
22. Zou G., A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159 (7): 702-6.
23. Breslow NE, Day NE., Statistical methods in cancer research. Volume II-The design and analyses of cohort studies. IARC Sci Publ. 1987;(82): 1-406.
24. Martelli S, Pivonka P, Ebeling PR., Femoral shaft strains during daily activities: implications for atypical femoral fractures. Clin Biomech (Bristol, Avon). 2014; 29 (8): 869-76.
25. Feskanich D, Willett W, Colditz G., Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002; 288 (18): 2300-6.
26. Woodcock J, Franco OH, Orsini N, Roberts I,. Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies. Int J Epidemiol. 2011; 40 (1): 121-38.
27. Fried LP, Tangen CM, Walston J, et al., Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56 (3): M146-56.
28. Leong DP, Teo KK, Rangarajan S, et al., Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015; 386 (9990): 266-73.
29. Cooper R, Kuh D, Hardy R, et al., Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010; 341: c4467.
30. Ensrud KE, Ewing SK, Cawthon PM, et al., A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc. 2009; 57 (3): 492-8.
31. Ensrud KE, Ewing SK, Taylor BC, et al., Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008; 168 (4): 382-9.
32. Neuman MD, Silber JH, Magaziner JS, Passarella MA, Mehta S, Werner RM., Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern Med. 2014; 174 (8): 1273-80.
33. Joseph B, Pandit V, Zangbar B, et al., Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis. JAMA Surg. 2014; 149 (8): 766-72.
34. Smith T, Pelpola K, Ball M, Ong A, Myint PK., Pre-operative indicators for mortality following hip fracture surgery: a systematic review and meta-analysis. Age Ageing. 2014; 43 (4): 464-71.
35. Karagiannis A, Papakitsou E, Dretakis K, et al., Mortality rates of patients with a hip fracture in a southwestern district of Greece: ten-year follow-up with reference to the type of fracture. Calcif Tissue Int. 2006; 78 (2): 72-7.
36. Haentjens P, Autier P, Barette M, et al., Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone. 2007; 41 (6): 958-64.
37. Michaelsson K, Weiderpass E, Farahmand BY, et al., Differences in risk factor patterns between cervical and trochanteric hip fractures. Swedish Hip Fracture Study Group. Osteoporos Int. 1999; 10 (6): 487-94.
38. Mautalen CA, Vega EM, Einhorn TA., Are the etiologies of cervical and trochanteric hip fractures different ? Bone. 1996; 18: 133.
39. Kharazmi M, Michaelsson K, Hallberg P., Prodromal symptoms in patients with bisphosphonate-associated atypical fractures of the femur. J Bone Miner Metab. 2015; 33 (5): 516-22.
40. Schilcher J, Aspenberg P., Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop. 2009; 80 (4): 413-5.
41. Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE., Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med. 2012; 172 (12): 930-6.
42. Patel KV, Brennan KL, Davis ML, Jupiter DC, Brennan ML., High-energy femur fractures increase morbidity but not mortality in elderly patients. Clin Orthop Relat Res. 2014; 472 (3): 1030-5.
43. Ettinger B, Burr DB, Ritchie RO., Proposed pathogenesis for atypical femoral fractures: lessons from materials research. Bone. 2013; 55 (2): 495-500.
44. Grey A, Bolland MJ., The effect of treatments for osteoporosis on mortality. Osteoporos Int. 2013; 24 (1): 1-6.
45. Gedeborg R, Thiblin I, Byberg L, Wernroth L, Michaelsson K,. The impact of clinically undiagnosed injuries on survival estimates. Crit Care Med. 2009; 37 (2): 449-55.